why is compounded tirzepatide banned FDA BANS Tirzepatide! Now What? Troubling Findings in Study of

At 15mg: -16.8

no clear plateau) Zepbound: ~20% to 22.5% (long-term studies) Glycemic Control (T2D): Retatrutide: HbA1c reduction up to ~2.0% (Phase III) Zepbound: Strong, well-established HbA1c reductions (~2.0% to 2.4%) across Phase III trials Durability of Effect: Retatrutide: Sustained weight loss with continued decline over time Zepbound: Durable, but tends to plateau earlier Safety & Tolerability: Retatrutide: Higher rates of GI side effects

D.le RouxC

1 These products feature portion-controlled options, such as grain bowls, mini flatbread pizzas with cauliflower crust, and high-protein sandwich melts designed to support the nutritional needs of individuals consuming smaller portions due to medication-induced appetite suppression

Beyond Injections: Holistic Wellness True long-term success requires a psychological shift from dieting to metabolic management. We encourage the integration of consistent strength training to support a higher resting metabolic rate, as lean muscle is your best defense against future weight gain